Cogent Biosciences Inc (COGT)
6.96
-0.16
(-2.25%)
USD |
NASDAQ |
Apr 23, 16:00
6.99
+0.03
(+0.43%)
After-Hours: 20:00
Cogent Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
Date | Value |
---|---|
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
QuidelOrtho Corp | 0.4824 |
NeuroOne Medical Technologies Corp | 0.00 |
Agios Pharmaceuticals Inc | 0.00 |
Tenon Medical Inc | 1.508 |
DIH Holding US Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 313.44M |
Total Liabilities (Quarterly) | 55.64M |
Shareholders Equity (Quarterly) | 257.80M |